Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lasser

Showing results (211-220 of 222) with videos related to

Pageof 23
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase I and pharmacological study of intra-arterial hepatic administration of pirarubicin in patients with advanced hepatic metastasesJ N Munck, P Rougier, G G Chabot, et al.
AJR. American Journal of Roentgenology|November 25, 2000
Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 yearT de Baere, D Elias, C Dromain, et al.
Cancer|September 15, 1989
Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma. A multivariate analysis, report of 106 cases, and review of the literatureM B Azab, M Henry-Amar, P Rougier, et al.
British Journal of Cancer|December 22, 1999
Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatinE Mitry, E Baudin, M Ducreux, et al.
Bulletin Du Cancer|October 1, 1998
[Importance of a multidisciplinary approach to metastatic cancer of the rectum]E Mitry, P L Pompili, P Rougier, et al.
The Journal of Clinical Endocrinology and Metabolism|January 27, 1999
Screening for multiple endocrine neoplasia type 1 and hormonal production in apparently sporadic neuroendocrine tumorsE Baudin, J M Bidart, P Rougier, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2004
The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option?Th Delaunoit, M Ducreux, V Boige, et al.
British Journal of Cancer|March 25, 2000
Extensive molecular screening for hereditary non-polyposis colorectal cancerB Dieumegard, S Grandjouan, J C Sabourin, et al.
Oncology|April 29, 2006
A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with pretreated gastroenteropancreatic well-differentiated endocrine carcinomasM P Ducreux, V Boige, S Leboulleux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2006
EGFR in colorectal cancer: more than a simple receptorM Francoual, M-C Etienne-Grimaldi, J-L Formento, et al.
Pageof 23

Showing results (211-220 of 222) with videos related to

Sort By:
Pageof 23
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase I and pharmacological study of intra-arterial hepatic administration of pirarubicin in patients with advanced hepatic metastasesJ N Munck, P Rougier, G G Chabot, et al.
AJR. American Journal of Roentgenology|November 25, 2000
Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 yearT de Baere, D Elias, C Dromain, et al.
Cancer|September 15, 1989
Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma. A multivariate analysis, report of 106 cases, and review of the literatureM B Azab, M Henry-Amar, P Rougier, et al.
British Journal of Cancer|December 22, 1999
Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatinE Mitry, E Baudin, M Ducreux, et al.
Bulletin Du Cancer|October 1, 1998
[Importance of a multidisciplinary approach to metastatic cancer of the rectum]E Mitry, P L Pompili, P Rougier, et al.
The Journal of Clinical Endocrinology and Metabolism|January 27, 1999
Screening for multiple endocrine neoplasia type 1 and hormonal production in apparently sporadic neuroendocrine tumorsE Baudin, J M Bidart, P Rougier, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2004
The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option?Th Delaunoit, M Ducreux, V Boige, et al.
British Journal of Cancer|March 25, 2000
Extensive molecular screening for hereditary non-polyposis colorectal cancerB Dieumegard, S Grandjouan, J C Sabourin, et al.
Oncology|April 29, 2006
A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with pretreated gastroenteropancreatic well-differentiated endocrine carcinomasM P Ducreux, V Boige, S Leboulleux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2006
EGFR in colorectal cancer: more than a simple receptorM Francoual, M-C Etienne-Grimaldi, J-L Formento, et al.
Pageof 23